Ryuya Yamanaka

4.6k citations
110 papers · 3.5k indexed · h-index 32
Topics
Glioma Diagnosis and Treatment (28 papers)Immunotherapy and Immune Responses (25 papers)CNS Lymphoma Diagnosis and Treatment (22 papers)

In The Last Decade

Ryuya Yamanaka

109 papers receiving 3.4k citations

Peers

Ryuya Yamanaka
Comparison fields: 5 of 113
  • Immunology 1.4k
  • Molecular Biology 1.3k
  • Oncology 1.1k
  • Genetics 806
  • Neurology 444
Replace Sara M. Bodner with:
Sara M. Bodner United States
Maria Carla Bosco Italy
Hitoshi Kohsaka Japan
D. Wade Clapp United States
Marco Forni Italy
Finbarr E. Cotter United Kingdom
Roland P. Piekorz Germany
Lawrence C. Kenyon United States
Neil V. Morgan United Kingdom
Idit Shachar Israel
Ryuya Yamanaka relative to Sara M. Bodner United States Sara M. Bodner's profile →
Citations per field
00.5×5.0×
Sara M. Bodner · 1×
Citations per year

Countries citing papers authored by Ryuya Yamanaka

Since Specialization
Citations

This map shows the geographic impact of Ryuya Yamanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuya Yamanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuya Yamanaka more than expected).

Fields of papers citing papers by Ryuya Yamanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuya Yamanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuya Yamanaka. The network helps show where Ryuya Yamanaka may publish in the future.

Co-authorship network of co-authors of Ryuya Yamanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuya Yamanaka. A scholar is included among the top collaborators of Ryuya Yamanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuya Yamanaka. Ryuya Yamanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 9
3 24
4 31
5 32
6 2
7 10
8 56
9 36
10 48
11 113
12 15
13 17
14 30
15 12
16 11
17 7
18 1
19 21
20 2

About Ryuya Yamanaka

Ryuya Yamanaka is a scholar working on Genetics, Neurology and Immunology, having authored 110 papers that have together received 3.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (28 papers), Immunotherapy and Immune Responses (25 papers) and CNS Lymphoma Diagnosis and Treatment (22 papers). The work is most often cited by research in Genetics (806 citations), Immunology (1.4k citations) and Oncology (1.1k citations). Ryuya Yamanaka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Azusa Hayano, Ryuichi Tanaka, Kleanthis G. Xanthopoulos, Naoki Yajima, Naoto Tsuchiya, Masakazu Sano, Yasuo Takashima, Jumpei Homma, Julie Lekstrom-Himes and Tsutomu Kobayashi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026